Category: Pharmaceutical Manufacturing - Page 2

In 2025, the pharmaceutical landscape in the USA is heavily influenced by the operations of its top three distributors. These companies form an integral part of the healthcare supply chain, bridging the gap between manufacturers and end consumers. For Indian pharmaceutical manufacturers aiming to penetrate the US market, understanding these distributors' roles and strategies can offer significant advantages. This article examines the Big 3 pharma distributors and their impact on industry dynamics.

AbbVie and Abbott are two significant names in the pharmaceutical industry. Both companies have a shared history, but they operate independently since their separation in 2013. This article provides insights into their individual roles and collaborations, particularly in the context of the Indian pharmaceutical market. It also explores the strategic decisions that have shaped their paths and their impact on innovation and healthcare.